Atlas Trials

Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma

Clinical trial NCT03325101 · TERMINATED

Trial details

NCT number
NCT03325101
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
Start date
2017-11-15
Primary completion
2020-06-14
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.